EUVIMEDEUVIMED entdecken
Fallbericht

Ayurvedic management of HBV-Associated Chronic Liver Parenchymal Disease with Ascites: A Case Report

Dr. Malhar Nesari, Dr. Ninad Nangare

International Journal of Drug Delivery Technology · 13.04.2026 · 16 (9s)

DOI: 10.25258/ijddt.16.9s.11 ↗

Kurz gefasst

Fallbericht in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 13.04.2026. Verfasst von Dr. Malhar Nesari und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic Liver Parenchymal Disease (CLPD) is a progressive hepatic condition damaging the functional parenchyma, often due to viral hepatitis (HBV), metabolic disorders, or toxins, leading to fibrosis, cirrhosis, ascites, and complications like portal hypertension. CASE PRESENTATION: A 61-year-old female patient presented in May 2025 with body weight 59 kg, moderate ascites, pain in the right hypochondriac and epigastric regions, anorexia, and generalized weakness for two months. History included diabetes and HBsAg-positive chronic HBV. Clinical findings: palpable splenomegaly, ascites; USG abdomen showed coarse liver echotexture, borderline splenomegaly, moderate ascites; initial LFTs: bilirubin 1.31 mg/dL, SGOT (AST) 57 U/L, SGPT (ALT) 39 U/L. Diagnosed as CLPD.

Intervention

A four-month herbo-mineral Ayurvedic regimen: May-June - Trailokya Chintamani Rasa, Tamra Bhasma, Pippali, Haritaki with detox diet; July (during HBV flare with bilirubin spike to 9.12 mg/dL) - Guduchi, Sootshekhar Rasa, Triphala, Nimb, Sariva, Manjishtha, Bawachi; August - Phalatrikadi Guggulu, Gandharva Haritaki, Guduchi, Loha Bhasma. Monthly LFT/USG abdomen monitoring. Outcome: Complete resolution of ascites, pain, anorexia; 3 kg weight loss. LFT normalization by August 30: bilirubin 0.81 mg/dL, SGOT (AST) 26.3 U/L, SGPT (ALT) 34 U/L. Follow-up USG abdomen showed mildly coarse liver echotexture with reduced ascites.

Conclusion

This case illustrates Ayurveda's potential to reverse CLPD through Yakrit-shodhana, Pitta-shamaka, and Rasayana therapies, even in HBV context with acute flares. Demonstrates safety and efficacy as integrative approach; warrants larger clinical trials. Patient Consent: Written informed consent was obtained from the patient for publication of this case report and clinical details. Conflict of Interest: The authors declare no conflict of interest.

Zitieren

APA

Nesari, D. M., & Nangare, D. N. (2026). Ayurvedic management of HBV-Associated Chronic Liver Parenchymal Disease with Ascites: A Case Report. International Journal of Drug Delivery Technology, 16(9s). https://doi.org/10.25258/ijddt.16.9s.11

Vancouver

Nesari DM, Nangare DN. Ayurvedic management of HBV-Associated Chronic Liver Parenchymal Disease with Ascites: A Case Report. International Journal of Drug Delivery Technology. 2026;16(9s). doi:10.25258/ijddt.16.9s.11

BibTeX
@article{Nesari2026,
  author = {Nesari, Dr. Malhar and Nangare, Dr. Ninad},
  title = {Ayurvedic management of HBV-Associated Chronic Liver Parenchymal Disease with Ascites: A Case Report},
  journal = {International Journal of Drug Delivery Technology},
  year = {2026},
  volume = {16},
  number = {9s},
  doi = {10.25258/ijddt.16.9s.11}
}
Kostenlos starten →